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Objective: To investigate and characterize the chemical composition of the different
crude extracts from the leaves of Broussonetia luzonica (Blanco) (Moraceae)
(B. luzonica), an endemic plant in the Philippines.
Methods: The air dried leaves were powdered and subjected to selective sequential
extraction using solvents of increasing polarity through percolation, namely, n-hexane,
ethyl acetate and methanol to obtain three different extracts. Then, each of the extracts
was further subjected to gas chromatography–mass spectrometry.
Results: Qualitative determination of the different biologically active compounds from
crude extracts of B. luzonica using gas chromatography–mass spectrometry revealed
different types of high and low molecular weight chemical entities with varying quantities
present in each of the extracts. These chemical compounds are considered biologically
and pharmacologically important. Furthermore, the three different extracts possess unique
physicochemical characteristics which may be attributed to the compounds naturally
present in signiﬁcant quantities in the leaves of B. luzonica.
Conclusions: The three extracts possess major bioactive compounds that were identiﬁed
and characterized spectroscopically. Thus, identiﬁcation of different biologically active
compounds in the extracts of B. luzonica leaves warrants further biological and phar-
macological studies.1. Introduction
Plants play a signiﬁcant role in the prevention and treatment of
diseases and can even prevent and reduce the adverse effects of
conventional treatments [1]. They can be a source of chemical
compounds of biological and pharmacological importance.
History reveals that plants are sources of successful drugs, and
will continuously be important for screening of new
lead compounds [2]. An essential part in the investigation of plant
is the identiﬁcation of the biologically active compounds present
in plant leading to further biological and pharmacological studies
[3–5]. Broussonetia luzonica (Blanco) (Moraceae) (B. luzonica), a
tree endemic in the Philippines, is commonly found in thicketsand forests at low and medium altitudes. For Filipinos especially
those from the northern part of Luzon, the leaves and ﬂowers are
edible and used in vegetable recipes such as pinakbet and
bulanglang [6,7]. Compounds present in other species of
Broussonetia exhibited remarkable biological activities.
Broussonetia papyrifera exhibited potent antiproliferative effects
on estrogen receptor-positive MCF-7 breast cancer cells in vitro
[5]; furthermore, its methanolic extract exhibited cytotoxicity
against HeLa cell lines and HepG2 cell lines [8]. Plants under the
same genus might also exhibit the same biological activities
because of similar active principles present in them [9].
Identiﬁcation of bioactive compounds present in the leaves of
B. luzonica is conducted for further reference of future studies on
one of the edible and endemic plants of the Philippines. There
are no published literatures that determine the bioactive
compounds present in the different extracts of B. luzonica leaves
by gas chromatography–mass spectrometry (GC–MS) analysis.
This study aimed to investigate and characterize the bioactive
compounds in the different crude extracts of B. luzonica leaves.article under the CC BY-NC-ND license (http://
Table 2
Biologically active chemical compounds of n-hexane extract from
B. luzonica leaves.
Name of compounds
(molecular formula)
Retention
time (min)
%
9,12,15-Octadecatrienoic acid,
methyl ester, (Z,Z,Z)- (C19H32O2)
51.56 4.421
Heneicosane (C21H44) 52.68 3.291
Tricosane (C23H48) 53.70 6.315
Tetracosane (C24H50) 54.62 8.626
Triacontane (C30H62) 55.46 7.341
Hexacosane (C26H54) 56.26 5.534
Octacosane (C28H58) 57.75 1.660
2,6,10,14,18,22-Tetracosahexaene,
2,6,10,15,19,23-hexamethyl-,
(all-E)- or squalene (C30H50)
58.06 29.028
Table 1
Biologically active chemical compounds of methanol extract from
B. luzonica leaves.
Name of compounds (molecular formula) Retention
time (min)
%
Benzene, 1,2,3-trimethyl (C9H12) 9.26 2.506
Phytol (C20H40O) 51.72 6.739
Tritriacontane (C33H68) 55.42 16.670
g-Sitosterol (C29H50O) 55.81 14.754
b-Sitosterol (C29H50O) 56.08 3.065
Androst-5-en-17-ol, 4-4-dimethyl (C21H34O) 56.11 4.185
Hentriacontane (C31H64) 56.43 1.862
Lup-20(29)-en-3-one (C30H48O) 57.17 8.091
Lupeol (C30H50O) 57.70 21.973
Table 3
Biologically active chemical compounds of ethyl acetate extract from
B. luzonica leaves.
Name of compounds
(molecular formula)
Retention
time (min)
%
1,2,3-Propanetriol,
monoacetate (C5H10O4)
20.08 21.211
1,2,3-Propanetriol,
diacetate (C7H12O5)
24.60 4.351
Hexadecanoic acid,
ethyl ester (C18H36O2)
50.11 2.386
Phytol (C20H40O) 51.70 20.288
9,12,15-Octadecatrienoic
acid, methyl ester,
(Z,Z,Z)- (C19H32O2)
51.56 2.465
(continued on next page)
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2.1. Plant sample
Fresh leaves of the endemic plant B. luzonica were collected
from Solano, Nueva Vizcaya, Philippines in June 9–10, 2015.
Sample of plant was identiﬁed by a botanist and herbarium
curator of Research Center of Natural and Applied Sciences,
University of Santo Tomas, Manila and assigned with herbarium
accession number of 012978.
2.2. Extraction of crude extracts
The leaves of the plant were air dried at room temperature for
about 3 days. The dried leaves were ground using Wiley Mill
Model No. 2 (Arthur H. Thomas Co., Philadelphia, USA). Dried
and powdered samples were subjected to selective sequential
extraction using solvents of increasing polarity, namely, n-hex-
ane, ethyl acetate and methanol [10]. Then the extract was
evaporated to dryness using Heidolph Rotavapor (Germany).
2.3. The GC–MS analysis
The GC–MS analysis of bioactive compounds from the
different extracts of the leaves of B. luzonica was done using
Agilent Technologies GC systems with GC-7890A/MS-5975C
model (Agilent Technologies, Santa Clara, CA, USA) equipped
with HP-5MS column (30 m in length × 250 mm in
diameter × 0.25 mm in thickness of ﬁlm). Spectroscopic detection
by GC–MS involved an electron ionization system which utilized
high energy electrons (70 eV). Pure helium gas (99.995%) was
used as the carrier gas with ﬂow rate of 1 mL/min. The initial
temperature was set at 50 –150 Cwith increasing rate of 3 C/min
and holding time of about 10 min. Finally, the temperature was
increased to 300 C at 10 C/min. One microliter of the prepared
1% of the extracts diluted with respective solvents was injected in
an splitless mode. Relative quantity of the chemical compounds
present in each of the extracts of B. luzonica was expressed as
percentage based on peak area produced in the chromatogram.
2.4. Identiﬁcation of chemical constituents
Bioactive compounds extracted from different extracts of
B. luzonica were identiﬁed based on GC retention time on HP-
5MS column and matching of the spectra with computer software
data of standards (Replib and Mainlab data of GC–MS systems).
3. Results
3.1. Percentage yield
From three batches of approximately 1 kg of air dried
powdered leaves, mean percentage yields of 3.64% (SD = 0.33)
of n-hexane extract, 1.62% (SD = 0.05) of ethyl acetate extract
and 6.34% (SD = 0.32) of methanol extract were obtained.
Methanol extract gave the highest percentage yield. Most of the
constituents were polar in nature.
3.2. Physical properties
The different crude extracts from B. luzonica leaves possessed
unique physical characteristics. The n-hexane extract was yellowto yellow orange in color with agreeable odor; the pH was 5.79 in
10% aqueous solution and speciﬁc gravity was 1.02. The ethyl
acetate extract was brown to dark brown in color with ammoni-
acal odor; the pH was 5.22 in 10% aqueous solution and speciﬁc
gravity was 1.03. The methanol extract was green to dark green in
color with sweetened agreeable odor; the pH was 4.07 in 10%
aqueous solution having speciﬁc gravity of 2.4.
3.3. Bioactive compounds present in the extracts
The bioactive compounds present in methanol, n-hexane and
ethyl acetate extracts obtained from B. luzonica leaves are
shown in Tables 1–3. Their identiﬁcation and characterization
were based on their elution order in a HP-5MS column. The
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Table 3 (continued )
Name of compounds
(molecular formula)
Retention
time (min)
%
9,12,15-Octatrienoic acid,
ethyl ester, (Z,Z,Z)- (C20H34O2)
52.30 2.753
3,7,11,15-Tetramethyl-2-hexadecen-1-ol
(C20H40O)
52.90 6.765
2,6,10,14,18,22-Tetracosahexaene,
2,6,10,15,19,23-hexamethyl-,(all-E)-
or squalene (C30H50)
58.00 6.853
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bioactive compounds were also presented. Based on abundance,
the top three major compounds present in the methanolic extract
were lupeol (21.973%), tritriacontane (16.670%) and g-sitos-
terol (14.754%). The n-hexane crude extract contained squalene
(29.028%) followed by tetracosane (8.626%) and triacontane
(7.341%). The ethyl acetate crude extract had phytol (20.288%),
1,2,3-propanetriol, monoacetate (21.211%) and squalene (6.8%)
as the top three major compounds. The GC chromatograms of
the three extracts presented in Figures 1–3 show the retention46.99 48
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Figure 3. A typical chromatogram of the bioactive compounds present in n-hexane crude extract.
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the bioactive compounds present in the extract.
4. Discussion
Different crude extracts were obtained from the leaves of
B. luzonica through selective sequential extraction with solvents
of increasing polarity, namely, n-hexane, ethyl acetate and
methanol. GC–MS analysis of the n-hexane, ethyl acetate and
methanol extracts revealed the presence of various bioactive
compounds. Phytol is present both in methanol (6.739%) and
ethyl acetate extracts (20.288%) but in different quantities. In
addition, squalene and 9,12,15-octadecatrienoic acid, methyl
ester, (Z,Z,Z)- are both present in n-hexane and ethyl acetate
extracts. The three crude extracts did not reveal a common major
compound in them. Based on studies, some of the constituents
revealed by GC–MS are biologically active compounds. They
were proven to possess pharmacologic activities which may
contribute to the healing potential of the plant. Phytol was
proven to exhibit antioxidant and antinociceptive effects [11,12].
Phytol, precursor of synthetic vitamin E and vitamin K, was
found to be cytotoxic against breast cancer cell lines (MCF7)
[13,14]. Propanetriol monoacetate was conﬁrmed to be present
in other plants exhibiting antimicrobial, anti-inﬂammatory,
diuretic and anticancer effects [15]. Propanetriol monoacetate
was proven to be a precursor of tricetin (antifungal), but may
also serve as a prodrug and vehicle for anticancer agents [16].
In addition, phytosterols such as a-sitosterol and b-sitosterol
were proven to prevent cancer through targeting different
mechanisms leading to cancer. They were able to prevent
angiogenesis by increasing antioxidant enzymes and inhibiting
reactive oxygen species production and oxidative stress. These
sterols even blocked inﬂammatory cytokines and induced
apoptosis [17–19].
Other studies revealed that lupeol, squalene, tetracosane and tri-
acontane possess various pharmacological properties. Lupeol
exhibited marked anti-inﬂammatory and anticancer properties [20].
Several investigations revealed that lupeol blocks tumorigenesis byaffecting molecular growth pathways which are involved in cell
proliferation and cell death [21,22]. In vivo and in vitro tests revealed
potent anti-mutagenic property of lupeol [23–25]. Squalene has
antioxidant, chemopreventive, antitumor and hypocholesterolemic
activities [26,27]. Tetracosane showed cytotoxicity against AGS,
MDA-MB-231, HT29 and NIH 3T3 cells [28]. Triacontane
possesses antibacterial, antidiabetic and antitumor activities [29,30].
These biological activities of compounds present in
B. luzonica leaf extract support the medicinal application of the
plant. The study revealed major bioactive compounds present in
all of the extracts. Identiﬁcation of these compounds in the
plant serves as the basis in determining the possible health
beneﬁts of the plant leading to further biologic and pharma-
cologic studies.
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